Blood eosinophilia in patients with COPD, a real life evaluation

M. Baptista Duarte Barata (Almada, Portugal), T. Martín (Almada, Portugal), R. Gomes (Almada, Portugal), H. Grumete (Almada, Portugal), F. Menezes (Almada, Portugal), J. Duarte (Almada, Portugal)

Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Session: Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Session type: Poster Discussion
Number: 5466
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Baptista Duarte Barata (Almada, Portugal), T. Martín (Almada, Portugal), R. Gomes (Almada, Portugal), H. Grumete (Almada, Portugal), F. Menezes (Almada, Portugal), J. Duarte (Almada, Portugal). Blood eosinophilia in patients with COPD, a real life evaluation. 5466

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

Blood eosinophils and exacerbation rate in COPD patients over three years
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018



Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018

Blood eosinophils fluctuation in asthmatics on Omalizumab-a mirror of disease outcomes improvement?
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018


Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD
Source: Eur Respir J, 50 (5) 1701162; 10.1183/13993003.01162-2017
Year: 2017



Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015


Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017



The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018

24-hour blood pressure monitoring and clinical differentiations in patients with bronchial asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013


Peripheral blood eosinophil counts in COPD patients and its relationship with prescription of inhaled corticosteroid in real world setting in Japan.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017

Can blood eosinophils predict sputum eosinophils in stable COPD?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


Microbiological indicators from sputum of patients with exacerbation of COPD
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015


Small airway dysfunction in elderly patient with asthma: a real life study
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018




The pulmonary artery-aorta ratio, exacerbation rate and quality of life in stable COPD patients
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


Early discharge for patients with exacerbations of COPD - a real life cohort study
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005